Title : Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma.

Pub. Date : 2017 Mar

PMID : 27816492






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BACKGROUND & AIMS: Tremelimumab is a fully human monoclonal antibody that binds to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) on the surface of activated T lymphocytes. Adenosine Monophosphate cytotoxic T-lymphocyte associated protein 4 Homo sapiens
2 BACKGROUND & AIMS: Tremelimumab is a fully human monoclonal antibody that binds to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) on the surface of activated T lymphocytes. Adenosine Monophosphate cytotoxic T-lymphocyte associated protein 4 Homo sapiens